drugset
drugset / Trial / NCT01751321

Glucose Variability With DPP-4 Inhibition

NCT01751321 ↗

Unknown 50 enrolled Research Clinical Centre of the Russian Railways, JSC
Parallel-groupDouble-blindTreatment

Summary

Glucose Variability With DPP-4 Inhibition

Timeline

Start
2013-05
Primary completion
2013-09
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitagliptin Small molecule 50 mg —
Background Metformin Small molecule 1000 mg —

Indications

type 2 diabetes mellitus